Four new antibacterial xanthones from the marine-derived actinomycetes Streptomyces caelestis

50Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

Abstract

Four new polycyclic antibiotics, citreamicin θ A (1), citreamicin θ B (2), citreaglycon A (3), and dehydrocitreaglycon A (4), were isolated from marine-derived Streptomyces caelestis. The structures of these compounds were elucidated by 1D and 2D NMR spectra. All four compounds displayed antibacterial activity against Staphylococcus haemolyticus, Staphylococcus aureus, and Bacillus subtillis. Citreamicin θ A (1), citreamicin θ B (2) and citreaglycon A (3) also exhibited low MIC values of 0.25, 0.25, and 8.0 μg/mL, respectively, against methicillin-resistant Staphylococcus aureus (MRSA) ATCC 43300. © 2012 by the authors; licensee MDPI.

Cite

CITATION STYLE

APA

Liu, L. L., Xu, Y., Han, Z., Li, Y. X., Lu, L., Lai, P. Y., … Qian, P. Y. (2012). Four new antibacterial xanthones from the marine-derived actinomycetes Streptomyces caelestis. Marine Drugs, 10(11), 2571–2583. https://doi.org/10.3390/md10112571

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free